Pharmaceuticals ASX Stock News and Announcements

17 September 2024

New!
ECS secures exclusive agreement with Terphogz

ECS Botanics will manufacture and sell Terphogz™ cannabis products in Germany, Australia, and New Zealand.

ECS Botanics Terphogz Medicinal Cannabis Stock Market News Cannabis Industry

Posted on: 17/09/2024

Read More

27 August 2024

FY24 Results - Record Harvest, Profit and Revenue

ECS Botanics reports record revenue, profit, and harvest for FY24.

ECS Botanics Financial Results Medicinal Cannabis Stock Market News

Posted on: 27/08/2024

Read More

11 August 2024

Positive Phase 2a fibromyalgia results across all patients

Tryp Therapeutics reports 100% patient improvement in Phase 2a fibromyalgia trial.

Tryp Therapeutics Fibromyalgia Clinical Trial Psilocybin Stock Market News

Posted on: 11/08/2024

Read More

9 August 2024

Phase 2 trial shows significant improvements in Angelman

Neuren Pharmaceuticals reports significant improvements in Angelman syndrome treatment with NNZ-2591.

Neuren Pharmaceuticals Angelman Syndrome NNZ-2591 Clinical Trial Results Stock Market News

Posted on: 09/08/2024

Read More

8 August 2024

IDT Secures New Contract with Sanofi Australia

IDT Australia signs a significant contract with Sanofi for mRNA technology development.

IDT Australia Sanofi mRNA Technology Pharmaceutical Manufacturing Stock Market News

Posted on: 08/08/2024

Read More

31 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argenica Therapeutics advances Phase 2 trial and secures $12 million in funding.

Argenica Therapeutics Clinical Trial Stock Market News Biotechnology Neurology

Posted on: 31/07/2024

Read More
Quarterly Activities/Appendix 4C Cash Flow Report

Clarity Pharmaceuticals announces robust cash position and significant clinical milestones.

Clarity Pharmaceuticals Stock Market News Clinical Trials Radiopharmaceuticals

Posted on: 31/07/2024

Read More

30 July 2024

Quarterly Activities Report

Syntara announces significant progress in clinical trials for myelofibrosis and myelodysplastic syndrome.

Syntara Clinical Trials Myelofibrosis Myelodysplastic Syndrome Stock Market News

Posted on: 30/07/2024

Read More
Quarterly Appendix 4C Cash Flow Report

Syntara Limited reveals significant cash flow details for the quarter ending June 2024.

Syntara Limited Quarterly Cash Flow Stock Market News Financial Report

Posted on: 30/07/2024

Read More
Equity Raising Presentation

Syntara Limited announces a $5 million equity raising for clinical program funding.

Syntara Limited Equity Raising Clinical Trials Stock Market News Biotechnology

Posted on: 30/07/2024

Read More
Placement

Syntara Ltd raises A$5 million to fund Phase 2 clinical trials.

Syntara Ltd Stock Market News Clinical Trials Biotechnology Pharmaceuticals

Posted on: 30/07/2024

Read More

29 July 2024

Corporate Update

Melodiol Global Health secures $1.1 million through equity placement and loans.

Melodiol Global Health Capital Raise Stock Market News Equity Placement Loan Funding

Posted on: 29/07/2024

Read More
Strong Q4 Pushes Full-Year Revenue Ahead of Guidance

IDT Australia reports a significant revenue increase, surpassing guidance.

IDT Australia Q4FY24 Revenue Stock Market News Pharmaceutical Manufacturing

Posted on: 29/07/2024

Read More

23 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Invex Therapeutics updates on clinical trials, financials, and corporate developments.

Invex Therapeutics Clinical Trials Biopharmaceuticals Stock Market News

Posted on: 23/07/2024

Read More